Burlingame, CA, United States of America

David C Klonoff


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 219(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David C Klonoff: Innovator in Glucose Monitoring Technology

Introduction

David C Klonoff is a prominent inventor based in Burlingame, CA (US). He is known for his significant contributions to the field of medical technology, particularly in glucose monitoring systems. His innovative approach has led to the development of a reagent-less whole-blood glucose meter, which has the potential to improve patient care.

Latest Patents

David C Klonoff holds a patent for a reagent-less whole-blood analyte detection system. This system is designed to be deployed near a patient and features a source that emits a beam of radiation within a specific spectral band. The whole-blood system includes a detector positioned in the optical path of the beam, as well as a housing that accommodates both the source and the detector. Additionally, it incorporates a sample element that is strategically placed in the optical path, featuring a sample cell and a sample cell wall that allows for the transmittance of the beam of radiation in the designated spectral band. This innovative technology enhances the accuracy and convenience of glucose monitoring.

Career Highlights

Throughout his career, David C Klonoff has made significant strides in the medical technology sector. He is currently associated with Optiscan Biomedical Corporation, where he continues to develop cutting-edge solutions for healthcare. His work has garnered attention for its potential to revolutionize how glucose levels are monitored in patients.

Collaborations

David has collaborated with notable professionals in the field, including Bernhard B Sterling and Philip C Hartstein. These partnerships have contributed to the advancement of his innovative projects and have fostered a collaborative environment for research and development.

Conclusion

David C Klonoff is a key figure in the innovation of glucose monitoring technology. His patent for a reagent-less whole-blood glucose meter exemplifies his commitment to improving patient care through advanced medical solutions. His contributions continue to shape the future of healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…